Abstract:Biotransformation of bavachinin (1) was investigated using three fungal cell cultures of Aspergillus flavus ATCC 30899, Cunninghamella elegans CICC 40250 and Penicillium raistrickii ATCC 10490, respectively. Two major converted products were identified by LC/MS, H-1 NMR and C-13 NMR and X-ray diffraction. Two biocatalyst systems, A. flavus ATCC 30899 and C. elegans CICC 40250 cell cultures, showed a great capacity of hydroxylation and two hydroxyl groups were attached at C-2 '' and C-3 '' positions in the side chain of the bavachinin A-ring, resulting in the formation of the same compound with a name, (S)-64(R)-2,3-dihydroxy-3-methylbuty1)-2-(4-hydroxypheny1)-7-methoxychromen-4-one (2). On the other hand, P. raistricicii ATCC 10490 cell cultures possessed the ability to reduction at C-4 of the substrate C-ring, resulting in the production of (2S,4R)-2-(4-hydroxyphenyI)-7-methoxy-6-(3-methylbut-2-en-1-yl)chromen-4-ol (3). Furthermore, the in vitro anti-tumor activities of the above compounds were evaluated by MIT assay. Compared with the substrate (1), product 3 possessed stronger inhibition activity on the human breast cancer cell line (MCF-7) and slightly lower inhibition activities against Hep G2, HeLa, Hep-2 and A549 cells lines; while the hydroxyl product 2 possessed much lower inhibition activity on tumor cells lines, which might be related to the insertion of two hydroxyl groups. Compounds 2 and 3 were considered to be novel. It was also the first time to biotransform bavachinin (1) by these three fungi, which suggested the potential role of microbial enzymes to synthesize novel compounds from plant secondary metabolites.(C) 2013, The Society for Biotechnology, Japan. All rights Reserved.

Biotransformation of Cinobufagin by Cell Suspension Cultures of Catharanthus Roseus and Platycodon Grandiflorum

Glucosylation of Cinobufagin by Cultured Suspension Cells of Catharanthus Roseus

Specific 12Β-Hydroxylation of Cinobufagin by Filamentous Fungi

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Microbial hydroxylation of cinobufagin by Mucor spinosus.

Biotransformation of Bufadienolides by Cell Suspension Cultures of Saussurea Involucrata

Cytotoxic Biotransformed Products from Cinobufagin by Mucor Spinosus and Aspergillus Niger

Cytotoxic Resibufogenin Transformation Products from Cell Suspension Cultures of Platycodon Grandiflorum

Two New Compounds Derived from Bufalin

Biotransformation of Triptolide and Triptonide by Cell Suspension Cultures Ofcatharanthus Roseus

Identification of cinobufagin metabolites in the bile of rats.

Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

Biotransformation of chinensiolide B and the cytotoxic activities of the transformed products

Biotransformation of Bavachinin by Three Fungal Cell Cultures

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure–activity Relationship (SAR)

Microbial Hydroxylation of Bufalin by Cunninghamella Blakesleana and Mucor Spinosus.

Biotransformation of Α-Santonin by Cell Suspension Cultures of Five Plants

Intestinal Transport and Biotransformation of Resibufogenin and Cinobufagin in Chan Su via HPLC/APCI-MSn